LIPOCODE
DEAD

Serial Number

79198699

Owner

Numares AG

Attorney

Richard L. Byrne

Filing Date

Aug 15, 2016

Add to watchlist:

No watchlists yet
View on USPTO

LIPOCODE Trademark

Serial Number: 79198699 • Registration: 5348221

LIPOCODE is a trademark filed by Numares AG on August 15, 2016. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Numares AG (7 trademarks)

Regensburg 93053 , DE

Entity Type: 03

Trademark Details

Filing Date

August 15, 2016

Registration Date

December 5, 2017

Published for Opposition

September 19, 2017

Cancellation Date

June 21, 2024

Goods & Services

Computer software, namely, analytical software to obtain results from raw data, interface software for establishing connections to laboratory software and laboratory instrumentation, software for managing workflow processes, software for database management, software for the operation of spectrometers, and software for evaluating the results of spectroscopic investigations and measurements; machine readable data carriers, namely, prerecorded magnetic or optical data carriers featuring analytical software to obtain results from raw data, interface software for establishing connections to laboratory software and laboratory instrumentation, software for managing workflow processes, software for database management, software for the operation of spectrometers, and software for evaluating the results of spectroscopic investigations and measurements

Diagnostic preparations for medical or veterinary purposes; reagents for use in medical analysis; diagnostic reagents for medical use

Chemicals used in industry and science; chemical reagents, other than for medical or veterinary purposes; diagnostic preparations, other than for medical or veterinary purposes; diagnostic reagents, other than for medical use for sale in kit form

Medical services in the field of monitoring metabolic processes, of diagnosing metabolic disorders, cardiovascular disorders, cancer, dementia or diabetes, and of monitoring the treatment of metabolic disorders, cardiovascular disorders, cancer, dementia or diabetes; medical testing services for the analysis of samples taken from patients; medical analysis services for diagnosis and prognosis of diseases; consultancy and providing information for the aforesaid services, included in this class

Development, programming and implementation of analytical software to obtain results from raw data, interface software for establishing connections to laboratory software and laboratory instrumentation, software for managing workflow processes, software for database management, software for the operation of spectrometers, and software for evaluating the results of spectroscopic investigations and measurements; scientific and technological services, namely, scientific and biotechnological testing services as well as medical and pharmacological research services in the fields of spectroscopy, of analyses of body fluids or their metabolites, of plant extracts and extracts of fermentation processes, of identification and quantification of ingredients of chemical or biological compositions, of monitoring metabolic processes, of diagnosing metabolic disorders, cardiovascular disorders, cancer, dementia or diabetes, and of monitoring the treatment of metabolic disorders, cardiovascular disorders, cancer, dementia or diabetes; medical and scientific laboratory services for analytical tests; working on and evaluation of chemical analyses; consultancy and providing information for the aforesaid services, included in this class

Filing History

TOTAL INVALIDATION PROCESSED BY THE IB
Jun 6, 2025 INNT
GENERIC MADRID TRANSACTION SENT TO IB
May 7, 2025 XXSS
GENERIC MADRID TRANSACTION CREATED
May 7, 2025 XXCR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Feb 21, 2025 INTR
CANCELLED SECTION 71
Jun 21, 2024 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Dec 5, 2022 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
May 11, 2018 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 20, 2018 FICS
FINAL DISPOSITION PROCESSED
Mar 20, 2018 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 5, 2018 FICR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 26, 2018 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 26, 2018 REAP
REGISTERED-PRINCIPAL REGISTER
Dec 5, 2017 R.PR
PUBLISHED FOR OPPOSITION
Sep 19, 2017 PUBO
NOTICE OF PUBLICATION
Aug 30, 2017 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 15, 2017 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 14, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 14, 2017 CRFA
ASSIGNED TO LIE
Aug 11, 2017 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 18, 2017 TROA
REFUSAL PROCESSED BY IB
Feb 18, 2017 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 24, 2017 RFCS
REFUSAL PROCESSED BY MPU
Jan 24, 2017 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 19, 2017 RFCR
NON-FINAL ACTION WRITTEN
Jan 18, 2017 CNRT
APPLICATION FILING RECEIPT MAILED
Jan 17, 2017 MAFR
ASSIGNED TO EXAMINER
Jan 12, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 12, 2017 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jan 11, 2017 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 22, 2016 REPR